Anti-Obesity Pharmacotherapy
This track showcases advancements in weight-loss medications, including appetite suppressants, metabolic enhancers, and GLP-1–based therapies. Researchers will present clinical trial data, safety profiles, and dosing strategies. The session explores the integration of pharmacotherapy with lifestyle modifications for enhanced outcomes. Discussions include long-term efficacy, patient adherence, and emerging drug pipelines. Regulatory considerations and global approvals will be reviewed. Clinicians will benefit from updated therapeutic guidelines.